Shenyang Xingqi Pharmaceutical Co Ltd

300573 • SHE

¥42.07-¥0.12 (0.28%)

Estimate

P/E

19.8

EPS

2.12

Beta

0.236

Growth

Revenue, YoY

27.45%

Net income, YoY

41.48%

FCF, YoY

15.6%

Dividends

Dividend yield

4.75%

Annual payout

¥2.00

Next ex. div date

November 22, 26

Payout

23.42%

Div.growth, 5y

98.78%

Dividend growth streak

1 year

Div.rating

About the company

Ticker

300573

ISIN

CNE100002DV1

Country

China

Sector (GICS)

Healthcare

Shenyang Xingqi Pharmaceutical Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of ophthalmic drugs in the People's Republic of China. The company offers myopia prevention and control medications, nutrition and corneal repair drugs, ophthalmic anti-inflammatory and anti-infective drugs, artificial tears and eye lubricants, ophthalmic non-steroidal anti-inflammatory drugs, intraocular rinsing fluids, pupil dilatant and ciliary muscle paralyzers, anti-fatigue medicines, dry eye treatment medicines, mydriatics and cycloplegia drugs, miotics and anti-glaucoma drugs, and intraoperative intraocular irrigation fluids. It also engages in technology development, technical advice, eye hospital, and research and experimental development activities. Shenyang Xingqi Pharmaceutical Co.,Ltd. was founded in 1977 and is based in Shenyang, the People's Republic of China.

Frequently asked questions

What sector does Shenyang Xingqi Pharmaceutical Co Ltd (300573) operate in?

Shenyang Xingqi Pharmaceutical Co Ltd belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.

What is Shenyang Xingqi Pharmaceutical Co Ltd (300573) current stock price?

As of the latest data, Shenyang Xingqi Pharmaceutical Co Ltd stock price is CN¥42.07, with a previous close of CN¥42.19. Shenyang Xingqi Pharmaceutical Co Ltd lost -CN¥0.12 in the last trading session, representing a -0.28% loss.

What is Shenyang Xingqi Pharmaceutical Co Ltd (300573) current market capitalization?

Shenyang Xingqi Pharmaceutical Co Ltd market cap is approximately 15.03 billion.

What is Shenyang Xingqi Pharmaceutical Co Ltd (300573) Earnings Per Share (EPS)?

The trailing EPS is CN¥2.12.

What is Shenyang Xingqi Pharmaceutical Co Ltd (300573) Price-to-Earnings (P/E) ratio?

Shenyang Xingqi Pharmaceutical Co Ltd current P/E ratio is 19.84.

Does Shenyang Xingqi Pharmaceutical Co Ltd (300573) pay dividends?

Yes. Shenyang Xingqi Pharmaceutical Co Ltd pays semiannual dividends with an annualized yield of 4.75% and an estimated annual payout of CN¥2.00 per share.

When is the next ex-dividend date for Shenyang Xingqi Pharmaceutical Co Ltd (300573)?

The next ex-dividend date is scheduled for November 22, 2026.

What is Shenyang Xingqi Pharmaceutical Co Ltd (300573) beta (volatility) score?

Shenyang Xingqi Pharmaceutical Co Ltd has a beta of 0.236, indicating lower volatility than the overall market.